35Pharma
Latest round
- Series C
Last raised
- Nov 2024
Total raised
- $53M
Investors
- 10
About 35Pharma
a. 35Pharma operates as a clinical-stage biopharmaceutical company that specializes in creating biologics to address critical health issues, particularly those related to the TGF-beta superfamily. In February 2026, GlaxoSmithKline Plc, agreed to acquire 35Pharma Inc. 35Pharma’s primary product offerings include highly potent ligand traps designed to selectively neutralize pathological activins and growth differentiation factors (GDFs), with key candidates such as HS135 for pulmonary hypertension and HS235 for cardiometabolic diseases and obesity. These products are created through a rigorous process that combines advanced protein engineering with a deep understanding of TGF-beta structure-function relationships, ensuring optimal efficacy. The company's research and development efforts are primarily conducted in their state-of-the-art facilities in Montreal, Canada. 35Pharma's revenue model is centered around the development and commercialization of its biologics, specifically targeting partnerships with healthcare providers and pharmaceutical companies to facilitate market entry and distribution. The acquisition aims to provide GlaxoSmithKline Plc HS235 inclusion within the Respiratory, Immunology and Inflammation portfolio.
Who invested in 35Pharma
10 investors across 1 round
See all investors in 35Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 26, 2024
Amount
$53M
Investors
Questions about 35Pharma
Who invested in 35Pharma?
35Pharma has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 35Pharma raised?
35Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did 35Pharma last raise money?
35Pharma's most recent round on record is a Series C, in Nov 2024.
What does 35Pharma do?
35Pharma is a biotechnology company.
Where is 35Pharma headquartered?
35Pharma is headquartered in Montreal, Canada.
Which VCs invest in companies like 35Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at 35Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like 35Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.